| Device Classification Name |
Multiplex Nucleic Acid Detection System For Biothreat Agents
|
| 510(k) Number |
K261362 |
| Device Name |
Xpert Hemorrhagic Fever |
| Applicant |
| Cepheid |
| 904 Caribbean Dr. |
|
Sunnyvale,
CA
94089
|
|
| Applicant Contact |
Suzette Chance |
| Correspondent |
| Cepheid |
| 904 Caribbean Dr. |
|
Sunnyvale,
CA
94089
|
|
| Correspondent Contact |
Katy Reilly |
| Classification Product Code |
|
| Subsequent Product Code |
|
| Date Received | 04/27/2026 |
| Decision Date | 08/07/2026 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Immunology
|
| 510k Review Panel |
Microbiology
|
| FDA Review |
Decision Summary
|
| Type |
Dual Track
|
| Clinical Trials |
NCT07591740
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|